Ombow, >> CYDY <<
Has the company provided guidance for when the Phase 3 data will be released? Seems like it should have been released by now. I remember they dragged their feet in releasing the mild/mod Phase 2 data, and it had missed the primary endpoint.
The release of key binary data is the most dangerous time to be long a bio stock, especially with a big position. The time to be a 'pig long' (if there is one) is during the pre-event runup period. That's the period of weeks/months where the stock will run up in anticipation of the event. When the data is actually released, the smart thing is to be on the sidelines, or at least lighten up.
Ignore this rule at your own peril. Bad data and the $3.7 bil market cap will collapse, along with your money.
There are risks during the pre-event run up period also - for example the company can use the runup to do a financing, the trial data can be released ahead of schedule, the trial can be stopped for safety reasons, etc. But these risks are much less than sitting with a big long position right through a binary event. It only takes one trial failure to put you in the poorhouse if you have your butt hanging out with a huge position and you hold it through the event. Enough said, but BE CAREFUL..
